NASDAQ : DBVT

DBV Technologies S.A. — Financial statements

Healthcare · Biotechnology · France

Last price 9.49 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 561.70M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

DBV Technologies S.A. (DBVT) reported revenue of 3.76M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Operating Revenue3.76M5.64M4.15M15.73M4.84M5.71M
Revenue3.76M5.64M4.15M15.73M4.84M5.71M
Gross Profit3.76M5.64M4.15M15.73M4.84M5.71M
Selling, General & Admin67.57M36.01M31.40M31.94M25.93M34.91M
Research & Development144.47M116.68M89.34M60.22M75.54M70.34M
Operating Expenses212.04M152.69M120.74M92.16M101.47M105.24M
Operating Income-208.28M-147.06M-116.59M-76.43M-96.63M-99.53M
Interest Expense-512.00K
Interest & Investment Income1.10M601.00K2.73M3.71M427.00K425.00K
Other Non Operating Income (Expenses)1.50M-1.00K
EBT Excluding Unusual Items-206.19M-146.46M-113.86M-72.72M-96.20M-99.11M
Merger & Restructuring Charges920.00K
Pretax Income-206.19M-146.46M-113.86M-72.72M-96.20M-98.19M
Income Tax Expense1.09M491.00K55.00K7.00K70.00K-381.00K
Net Income-207.28M-146.95M-113.92M-72.73M-96.27M-97.81M
Net Income to Common-207.28M-146.95M-113.92M-72.73M-96.27M-97.81M
Shares Outstanding (Basic)371.21M139.57M97.00M95.12M77.38M54.92M
Shares Outstanding (Diluted)371.21M139.57M97.00M95.12M77.38M54.92M
EPS (Basic)-0.56-1.05-1.17-0.76-1.24-1.78
EPS (Diluted)-0.56-1.05-1.17-0.76-1.24-1.78
Free Cash Flow-191.76M-121.71M-106.81M-80.33M-56.42M-109.15M
Free Cash Flow Per Share-0.52-0.87-1.10-0.84-0.73-1.99
Gross Margin100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin-5,536.36%-2,609.23%-2,808.70%-485.97%-1,994.86%-1,743.78%
Profit Margin-5,509.91%-2,607.29%-2,744.35%-462.40%-1,987.49%-1,713.54%
Free Cash Flow Margin-5,097.31%-2,159.56%-2,573.16%-510.75%-1,164.74%-1,912.26%
EBITDA-205.48M-143.86M-63.27M-83.47M-91.16M
D&A For EBITDA2.80M3.19M13.16M13.16M8.38M
EBIT-208.28M-147.06M-116.59M-76.43M-96.63M-99.53M

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents165.70M194.17M32.46M141.37M209.19M77.30M
Cash & Short-Term Investments165.70M194.17M32.46M141.37M209.19M77.30M
Other Receivables16.15M10.39M15.45M11.20M32.94M
Receivables16.15M10.39M15.45M11.20M32.94M
Prepaid Expenses2.63M1.54M2.10M2.68M4.15M
Other Current Assets23.90M
Total Current Assets189.60M212.94M44.39M158.91M223.07M114.39M
Property, Plant & Equipment17.00M14.95M16.81M17.87M17.61M25.48M
Long-Term Investments5.19M4.31M2.07M1.77M2.67M
Other Intangible Assets22.00K40.00K58.00K10.00K22.00K
Other Long-Term Assets8.80M619.00K110.00K4.07M4.05M4.17M
Total Assets215.40M233.72M65.66M182.99M246.52M146.72M
Accounts Payable42.00M40.94M22.03M23.30M14.47M11.43M
Accrued Expenses13.69M7.29M7.83M5.87M6.71M
Current Portion of Long-Term Debt510.00K
Current Portion of Leases800.00K1.12M654.00K1.14M1.89M3.00M
Current Income Taxes Payable592.00K188.00K223.00K69.00K182.00K
Current Unearned Revenue2.14M4.15M
Other Current Liabilities15.70M1.69M968.00K4.84M5.08M5.42M
Total Current Liabilities58.50M58.02M31.14M37.34M29.52M31.40M
Long-Term Debt200.00K
Long-Term Leases6.50M5.41M6.30M4.53M1.13M7.15M
Pension & Post-Retirement Benefits790.00K1.01M
Other Long-Term Liabilities1.60M1.51M838.00K934.00K20.63M7.90M
Total Liabilities66.80M64.95M38.27M42.80M52.06M47.45M
Common Stock36.10M26.91M11.65M10.97M10.72M6.54M
Additional Paid-In Capital459.20M541.25M315.61M377.47M458.22M358.12M
Retained Earnings-334.80M-393.13M-286.38M-238.86M-259.58M-258.53M
Treasury Stock-1.00M-834.00K-1.31M-1.26M-1.11M-1.23M
Comprehensive Income & Other-10.90M-5.43M-12.19M-8.13M-13.80M-5.62M
Shareholders' Equity148.60M168.77M27.39M140.19M194.45M99.27M
Total Liabilities & Equity215.40M233.72M65.66M182.99M246.52M146.72M
Total Debt7.50M6.53M6.95M5.67M3.02M10.66M
Net Cash (Debt)158.20M187.64M25.50M135.70M206.17M66.64M
Net Cash Per Share0.431.340.261.432.661.21
Filing Date Shares Outstanding314.39M235.60M102.58M96.21M93.99M54.94M
Total Common Shares Outstanding314.20M235.60M102.58M96.21M93.99M54.94M
Working Capital131.10M154.92M13.25M121.58M193.55M82.99M
Book Value Per Share0.470.720.271.462.071.81
Tangible Book Value148.60M168.75M27.35M140.13M194.44M99.25M
Tangible Book Value Per Share0.470.720.271.462.071.81
Machinery32.09M27.65M25.42M27.55M
Construction In Progress1.16M1.19M4.47M4.39M

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-207.28M-146.95M-113.92M-72.73M-96.27M-97.81M
Depreciation & Amortization2.80M3.19M-925.00K-14.00M13.16M8.38M
Stock-Based Compensation12.87M5.39M4.62M6.02M5.03M3.12M
Other Operating Activities11.05M15.85M1.39M99.00K100.00K840.00K
Change in Accounts Receivable2.15M
Change in Inventory-12.28M-16.06M-1.39M
Change in Accounts Payable4.12M15.78M272.00K8.42M3.46M-7.56M
Change in Other Net Operating Assets371.00K1.62M5.48M-7.47M18.86M-17.36M
Operating Cash Flow-188.35M-121.18M-104.47M-79.65M-55.67M-108.24M
Capital Expenditures-3.42M-532.00K-2.34M-677.00K-754.00K-910.00K
Sale of Property, Plant & Equipment8.00K604.00K
Sale (Purchase) of Intangibles-6.00K-6.00K-3.00K-8.00K
Investment in Securities-706.00K-831.00K1.58M-131.00K647.00K-119.00K
Other Investing Activities-2.80M-1.00K
Investing Cash Flow-6.93M-1.37M-757.00K-808.00K-100.00K-433.00K
Long-Term Debt Repaid-474.00K-689.00K
Net Debt Issued (Repaid)-474.00K-689.00K
Issuance of Common Stock226.00M206.13M634.00K6.92M106.50M699.00K
Repurchase of Common Stock-200.00K-47.00K-154.00K
Other Financing Activities70.35M70.05M88.09M264.00K
Financing Cash Flow296.15M276.18M587.00K6.77M194.12M274.00K
Foreign Exchange Rate Adjustments-5.00M8.08M-4.27M5.87M-6.46M-10.65M
Miscellaneous Cash Flow Adjustments-1.00K-1.00K1.00K1.00K
Net Cash Flow95.88M161.71M-108.91M-67.83M131.89M-119.05M
Free Cash Flow-191.76M-121.71M-106.81M-80.33M-56.42M-109.15M
Free Cash Flow Margin-5,097.31%-2,159.56%-2,573.16%-510.75%-1,164.74%-1,912.26%
Free Cash Flow Per Share-0.52-0.87-1.10-0.84-0.73-1.99
Levered Free Cash Flow-124.78M-64.28M-71.61M-51.53M-20.01M-98.09M
Unlevered Free Cash Flow-124.46M-64.28M-71.61M-51.53M-20.01M-98.09M
Change in Working Capital-7.79M1.34M4.36M953.00K22.32M-22.77M

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization563.10M796.16M66.89M196.73M315.93M191.28M
Enterprise Value407.55M733.97M30.66M42.67M87.21M106.36M
Last Close Price9.4919.173.099.5315.3016.00
PS Ratio158.54141.2616.1112.5165.2233.51
PB Ratio4.014.722.441.401.621.93
P/TBV Ratio4.014.722.451.401.621.93
EV/Sales Ratio117.19130.237.392.7118.0018.63
Debt / Equity Ratio0.050.040.250.040.020.11
Net Debt / Equity Ratio-1.06-1.11-0.93-0.97-1.06-0.67
Net Debt / EBITDA Ratio0.771.302.152.470.73
Net Debt / FCF Ratio0.821.540.241.693.650.61
Asset Turnover0.020.040.030.070.030.03
Quick Ratio2.833.621.384.207.473.51
Current Ratio3.243.671.434.267.563.64
Return on Equity (ROE)-205.79%-149.83%-135.96%-43.46%-65.55%-64.19%
Return on Assets (ROA)-79.89%-61.40%-58.61%-22.24%-30.72%-29.70%
Return on Capital Employed (ROCE)-132.70%-83.70%-337.70%-52.50%-44.50%-86.30%
Earnings Yield-29.94%-18.46%-170.31%-36.97%-30.47%-51.13%
FCF Yield-32.15%-15.29%-159.69%-40.83%-17.86%-57.06%
Buyback Yield / Dilution-213.71%-43.90%-1.97%-22.92%-40.91%-1.52%